[1]吴海燕,解文静,吕向妮,等.外周血miR-24水平与急性心肌梗死患者预后的相关性分析[J].心血管病学进展,2020,(6):650.[doi:[DOI]10.16806/j.issn.1004-3934.2020.06.022]
　WU HaiyanXIE Wenjing,LV Xiangni,XUE Baobao.Correlation between Level of miR-24 in Peripheral Blood and Prognosis of Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(6):650.[doi:[DOI]10.16806/j.issn.1004-3934.2020.06.022]
点击复制

外周血miR-24水平与急性心肌梗死患者预后的相关性分析()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年6期
页码:
650
栏目:
论著
出版日期:
2020-06-25

文章信息/Info

Title:
Correlation between Level of miR-24 in Peripheral Blood and Prognosis of Patients with Acute Myocardial Infarction
作者:
吴海燕; 解文静; 吕向妮; 薛宝宝
(中国人民解放军空军军医大学第一附属医院陕西 西安 710032)
Author(s):
WU HaiyanXIE Wenjing;  LV Xiangni;  XUE Baobao
(The First Affiliated Hospital, Air Force Military Medical University of PLA, Xi’an, 710032, Shaanxi, China)
关键词:
急性心肌梗死; miR-24; 心功能指标; 预后
Keywords:
Acute myocardial infarction;  iR-24;  Cardiac function index;  Prognosis
DOI:
[DOI]10.16806/j.issn.1004-3934.2020.06.022
摘要:
目的 分析外周血miR-24水平与急性心肌梗死（AMI）患者预后的相关性分析。方法 收集2017年5月—2018年5月入院就诊的AMI患者92例，根据临床诊断确定为急性ST段抬高型心肌梗死（STEMI）患者39例、急性非ST段抬高型心肌梗死（NSTEMI）患者53例，另选取非冠心病患者34例作为对照组；采用qRT-PCR）法检测患者外周血中miR-24水平，比较分析AMI患者miR-24水平与心功能指标的相关性；随访至2019年5月31日，分析AMI患者出院后主要不良心血管事件（MACE）发生与外周血miR-24水平的关系。结果 STEMI组患者外周血miR-24水平显著低于NSTEMI组和对照组，肌钙蛋白cTnT）、肌酸激酶（CK）及肌酸激酶同工酶（CK-MB）水平显著高于NSTEMI组和对照组（P<0.05）；Pearson相关显示，AMI患者外周血miR-24水平分别与hs-cTnT、CK-MB及CK水平呈负相关（均P<0.05）；随访结果显示，AMI患者出院后有38例出现MACE，占比41.30%；MACE患者miR-24水平显著低于无MACE者（P<0.05）；当外周血miR-24≤2.37时，预测患者出现MACE的为0.817，95% CI为0.722~0.890。结论 外周血miR-24水平在AMI患者中异常降低，可作为预测患者预后的潜在血清标记物。
Abstract:
Objective To analyze correlation between level of miR-24 in peripheral blood and prognosis of patients with acute myocardial infarction (AMI). Methods A total of 92 AMI patients who were treated in the hospital during the period from May 2017 to May 2018 were collected. According to clinical diagnosis,it was confirmed that there were 39 cases with acute ST elevation myocardial infarction (STEMI) and 53 cases with non-acute ST elevation myocardial infarction (NSTEMI). 34 patients with non-coronary heart disease were enrolled as control group. The level of miR-24 in peripheral blood was detected by quantitative real-time polymerase chain reaction (qRT-PCR). The levels of miR-24 in peripheral blood were compared among all groups. The correlation between miR-24 level and cardiac function indexes in AMI patients was analyzed. The follow-up lasted till May 31,2019. The relationship between occurrence of major adverse cardiovascular events (MACE) and level of miR-24 in peripheral blood after discharge in AMI patients was analyzed. Results The level of miR-24 in peripheral blood in STEMI group was significantly lower than that in NSTEMI group and control group, while levels of high-sensitivity troponin(hs-cTnT), creatine kinase(CK) and CK-soenzyme(CK-MB) were significantly higher than those in NSTEMI group and control group (P<0.05). Pearson correlation analysis showed that miR-24 level was negatively correlated to levels of hs-cTnT,CK-MB and CK (P<0.05). Follow-up results showed that there were 38 AMI patients (41.30%) with MACE after discharge. The miR-24 level in MACE patients was significantly lower than that in patients without MACE (P<0.05). When miR-24 in peripheral blood was not higher than 2.37, area under ROC curve and 95% CI for predicting MACE were 0.817 and 0.722~0.890,respectively. Conclusion The level of miR-24 in peripheral blood is abnormally decreased in AMI patients,which can be applied as a potential serum marker to predict their prognosis

参考文献/References:

[1] 崔小豪杨志明. 和肽素在急性心肌梗死中的研究进展[J]. 心血管病学进展2019,40(5):726-729.
[2] Chang J,Liu X,Sun Y. Mortality due to acutemyocardial infarction in China from 1987 to 2014: Secular trends and age-period-cohort effects[J]. Int J Cardiol,2017,227:229-238.
[3] Gawinecka J,Sch?nrath F,von Eckardstein A. Acute aortic dissection: pathogenesis,risk factors and diagnosis[J]. Swiss Med Wkly,2017,147:14489.
[4] Vishnoi A,Rani S. MiRNA biogenesis and regulation of diseases:an overview[J]. Methods Mol Biol,2017,1509:1-10.
[5] Li S,Guo LZ,Kim MH,et al. Platelet microRNA for predicting acute myocardial infarction[J]. J Thromb Thrombolysis,2017,44(4):556-564.
[6] Pan LJ,Wang X,Ling Y,et al. MiR-24 alleviates cardiomyocyte apoptosis after myocardial infarction via targeting BIM[J]. Eur Rev Med Pharmacol Sci,2017,21(13):3088-3097.
[7] 褚福永,刘红旭,程敏,.急性冠状动脉综合征患者外周血微小RNA-24表达与细胞凋亡及炎性因子的相关性研究[J]. 中华老年心脑血管病杂志2016,18(8):808-811.
[8] 中国医师协会急诊医师分会中华医学会心血管病学分会中华医学会检验医学分会. 急性冠脉综合征急诊快速诊疗指南[J]. 中华急诊医学杂志2016,25(4):397-404.
[9] Tong X,Wang X,Wang C,et al. Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3[J]. Br J Biomed Sci,2017,75(1):7-12.
[10] Karwowski J,Gierlotka M,G?sior M,et al. Relationship between infarct artery location,acute total coronary occlusion,and mortality in STEMI and NSTEMI patients[J]. Pol Arch Intern Med,2017,127(6):401-411.
[11] Naqvi AR,Fordham JB,Ganesh B,et al. MiR-24,miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells[J]. Sci Rep,2016,6:32925.
[12] Chen W,Ou HS. Regulation of miR-24 on vascular endothelial cell function and its role in the development of cardiovascular disease[J]. Sheng Li Xue Bao,2016,68(2):201-206.
[13] Li Q,van Linda LW,Huang Y,et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes[J]. J Exp Med,208(3):549-560.
[14]王珏黄伟聪郑亮承等. MicroRNA-24对心肌梗死后心肌细胞凋亡的调控作用[J]. 中国病理生理杂志2013,29(4):18-24.
[15]Feldman L,Steg PG,Amsallem M,et al. Medically managed patients with non-ST-elevation acute myocardial infarction have heterogeneous outcomes,based on performance of angiography and extent of coronary artery disease[J]. Eur Heart J Acute Cardiovasc Care,2016,6(3):262-271.
[16] Doi T,Kataoka Y,Noguchi T,et al. Coronary artery ectasia predicts future cardiac events in patients with acute myocardial infarction[J]. Arterioscl Throm Vascul,2017,37(12):2350-2355.
[17] Tong J,Yu Q,Li C,et al. Successful revascularization of noninfarct related artery with chronic total occlusion among acute myocardial infarction patients: a systematic review and meta-analysis[J].Medicine (Baltimore),2018,97(3):e9655.
[18]Moura FA,Cintra R,Carvalho LSF,et al. Adverse outcome has a U-shaped relation with acute phase change in insulin sensitivity after ST-Elevation Myocardial Infarction[J]. Int J Cardiol,2017,254:16-22.

相似文献/References:

[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
　LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(6):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
　ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(6):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
　YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(6):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
　YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
　YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(6):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
　WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(6):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
　LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(6):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
　YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
　CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
　PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]

备注/Memo

备注/Memo:
收稿日期：2020-01-06
更新日期/Last Update: 2020-09-22